SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
不能吃桃
Lv1
50 积分
2023-08-14 加入
最近求助
最近应助
互助留言
LB1703 High induction dosing of risankizumab in patients with moderate-to-severe plaque psoriasis: Interim results from the phase 2 KNOCKOUT study
2个月前
已完结
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16‐week real‐life experience during the COVID‐19 pandemic
2个月前
已完结
Safety and efficacy results from the open label extension of a phase 2 trial of risankizumab, a selective IL-23p19 inhibitor in patients with active psoriatic arthritis
2个月前
已完结
A head‐to‐head comparison of risankizumab and ixekizumab for genital psoriasis: a real‐life, 24‐week, prospective study
2个月前
已完结
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study
2个月前
已完结
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients
2个月前
已完结
The Effectiveness of Risankizumab Following Guselkumab Failure in Moderate-to-Severe Psoriasis Patients: A Retrospective Study
2个月前
已完结
806 Long-Term Safety and Efficacy of Risankizumab Treatment in Patients With Crohn’s Disease: 3-Year Interim Results From the Ongoing Phase 2 Open-Label Extension Study
2个月前
已关闭
A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response
5个月前
已完结
Goal Setting and Health-Related Outcomes in Chronic Diseases: A Systematic Review and Meta-Analysis of the Literature From 2000 to 2020
8个月前
已完结
没有进行任何应助
速度真快
2个月前
点赞
5个月前
经核实为壁报 没有公开数据内容【积分已退回】
8个月前
文件为期刊abstract 不是文献本身
8个月前
帮大忙了
9个月前
帮大忙了
11个月前
帮大忙了
1年前
感谢,帮大忙了
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论